human | Q5 |
P496 | ORCID iD | 0000-0003-1812-6587 |
P735 | given name | Bradley | Q538847 |
Bradley | Q538847 | ||
P106 | occupation | researcher | Q1650915 |
Q79265143 | "Flush before fill" in children receiving automated peritoneal dialysis |
Q93218571 | A longitudinal analysis of the effect of anemia on health-related quality of life in children with mild-to-moderate chronic kidney disease |
Q90210272 | A longitudinal examination of parent-reported emotional-behavioral functioning of children with mild to moderate chronic kidney disease |
Q92928969 | A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children |
Q90101364 | A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis |
Q72276415 | A seven year experience with kidney transplantation for pediatric end stage renal disease |
Q40500978 | ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney |
Q33443146 | ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB). |
Q40749201 | APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts |
Q93196126 | Academic achievement in children with chronic kidney disease: a report from the CKiD cohort |
Q102130088 | Achieved clinic blood pressure level and chronic kidney disease progression in children: a report from the Chronic Kidney Disease in Children cohort |
Q38819168 | Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease. |
Q89587438 | Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization |
Q94600317 | Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study |
Q43856026 | Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project |
Q74663164 | Adverse effect of peritonitis on peritoneal membrane function in children on dialysis |
Q68544284 | Advisability of initiating chronic peritoneal dialysis in the presence of a ventriculoperitoneal shunt |
Q104268572 | Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease |
Q50621603 | Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD. |
Q71110693 | Allocation of kidneys to Afro-American patients is proportional to wait-list composition |
Q38748543 | Ambulatory Blood Pressure Control in Children and Young Adults After Kidney Transplantation. |
Q38741095 | Ambulatory Blood Pressure, Left Ventricular Hypertrophy, and Allograft Function in Children and Young Adults After Kidney Transplantation. |
Q36226045 | Ambulatory blood pressure patterns in children with chronic kidney disease |
Q48309663 | Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis. |
Q36173980 | An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects |
Q91120765 | An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis |
Q37042133 | Anemia and risk of hospitalization in pediatric chronic kidney disease |
Q53354670 | Anemia in chronic kidney disease. |
Q47698825 | Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project |
Q46828754 | Anthropometric prediction of total body water in children who are on pediatric peritoneal dialysis |
Q68920292 | Anti-neutrophil cytoplasmatic antibodies in drug-induced Wegener-like disease |
Q74083409 | Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium |
Q92657048 | Aortic dilatation in children with mild to moderate chronic kidney disease |
Q93137853 | Are There Consequences of Adolescent Blood Pressure on Kidney Function in Adulthood? |
Q40559559 | Assessment of dietary intake of children with chronic kidney disease. |
Q98293278 | Association Between Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKiD) Study |
Q34362651 | Association between clinical risk factors and progression of chronic kidney disease in children |
Q36381297 | Association between common iron store markers and hemoglobin in children with chronic kidney disease |
Q40718544 | Association of blood pressure variability and neurocognition in children with chronic kidney disease |
Q37341665 | Association of income level with kidney disease severity and progression among children and adolescents with CKD: a report from the Chronic Kidney Disease in Children (CKiD) Study |
Q37152477 | Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study |
Q46273591 | Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study |
Q91997808 | Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract |
Q70489446 | Automated enzymatic determination of inulin |
Q37411633 | BP control and left ventricular hypertrophy regression in children with CKD. |
Q47309494 | Barriers for implementation of intensified hemodialysis: survey results from the International Pediatric Dialysis Network. |
Q91977638 | Bicarbonate, blood pressure, and executive function in pediatric CKD-is there a link? |
Q30502478 | Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study |
Q36392732 | CKiD (CKD in children) prospective cohort study: a review of current findings. |
Q36296577 | Can office blood pressure readings predict masked hypertension? |
Q44745968 | Capnocytophaga canimorsus peritonitis in a pediatric peritoneal dialysis patient |
Q35985737 | Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. |
Q90449615 | Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children |
Q40581024 | Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD. |
Q92566694 | Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study |
Q36443220 | Carotid intima-media thickness in children with CKD: results from the CKiD study |
Q35165493 | Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study |
Q33797077 | Ceramides and cardiac function in children with chronic kidney disease. |
Q48309655 | Cerebral vasculitis in acute post-streptococcal glomerulonephritis. |
Q91234218 | Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD |
Q96580865 | Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients |
Q43507845 | Chest wall peritoneal dialysis catheter placement in infants with a colostomy |
Q89156925 | Childhood Kidney Disease: A Troubling Prognosis? |
Q40150664 | Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project |
Q41680273 | Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study |
Q50109309 | Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. |
Q91248880 | Chronic dialysis in children and adolescents: challenges and outcomes |
Q36120049 | Chronic kidney disease in children: the global perspective |
Q94523012 | Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis |
Q70989780 | Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis |
Q82558426 | Cisplatin pharmacokinetics in a child receiving peritoneal dialysis |
Q44177364 | Citrate clearance in children receiving continuous venovenous renal replacement therapy |
Q70153522 | Clinical quiz. Bilateral renal artery stenosis |
Q54542807 | Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. |
Q40112299 | Cognitive Function in Children with Lupus Nephritis: A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases |
Q40708370 | Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft |
Q91048939 | Colostomy in children on chronic peritoneal dialysis |
Q88594607 | Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease |
Q36474198 | Comorbidities in chronic pediatric peritoneal dialysis patients: a report of the International Pediatric Peritoneal Dialysis Network |
Q83358126 | Comparison of single-pool and equilibrated Kt/V values for pediatric hemodialysis prescription management: analysis from the Centers for Medicare & Medicaid Services Clinical Performance Measures Project |
Q44478084 | Comparison of the safety and efficacy of 3 iron sucrose iron maintenance regimens in children, adolescents, and young adults with CKD: a randomized controlled trial |
Q50091275 | Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy. |
Q70575976 | Congenital nephrosis in association with hypothyroidism and hypoadrenocorticism |
Q91739561 | Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy |
Q36474366 | Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. |
Q73535401 | Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis |
Q93218573 | Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic |
Q47353724 | Contribution of symmetric dimethylarginine to GFR decline in pediatric chronic kidney disease |
Q47554855 | Controversy About Dialysis for an Adolescent |
Q90397259 | Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis |
Q97545686 | Correction to: Aortic dilatation in children with mild to moderate chronic kidney disease |
Q89986191 | Correction to: Mode of initial renal replacement therapy and transplant outcomes in the chronic kidney disease in children (CKiD) study |
Q34255349 | Correlates of leptin in children with chronic kidney disease |
Q36557932 | Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort |
Q74314596 | Creatinine clearance following cimetidine for estimation of glomerular filtration rate |
Q67264257 | Creatinine excretion rates for evaluation of kidney function in children |
Q52410503 | Creatinine for estimation of glomerular filtration rate. |
Q37395884 | Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors |
Q43529991 | Current approach to peritoneal access in North American children: a report of the Pediatric Peritoneal Dialysis Study Consortium |
Q39180221 | Cystatin C and Cardiac Measures in Children and Adolescents With CKD. |
Q83841453 | Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease |
Q45065477 | De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease |
Q72633839 | Defective antibody response to Hemophilus influenzae type b immunization in children receiving peritoneal dialysis |
Q35985679 | Defining left ventricular hypertrophy in children on peritoneal dialysis |
Q93243576 | Delayed menarche in girls with chronic kidney disease and the association with short stature |
Q98165452 | Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce |
Q36862404 | Depressive Symptoms in Children with Chronic Kidney Disease |
Q30419884 | Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study |
Q39155028 | Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative |
Q70855610 | Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRA |
Q97565311 | Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey |
Q40981589 | Dialysis and renal transplantation in infants with irreversible renal failure. |
Q33606206 | Dialysis-associated peritonitis in children |
Q45178299 | Dialysis: Vascular access in children--arteriovenous fistula or CVC? |
Q40330814 | Dietary sources of energy and nutrient intake among children and adolescents with chronic kidney disease |
Q38251157 | Difficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes |
Q37553097 | Disordered FGF23 and mineral metabolism in children with CKD |
Q46687218 | Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization? |
Q39569177 | Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm |
Q35214167 | Duration of chronic kidney disease reduces attention and executive function in pediatric patients |
Q35568634 | Dyslipidemia in children with chronic kidney disease |
Q43657701 | Echo-Doppler assessment of the biophysical properties of the aorta in children with chronic kidney disease. |
Q87979621 | Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population |
Q44645342 | Effect of donor brain-death duration on graft outcome |
Q40012831 | Effect of elevated blood pressure on quality of life in children with chronic kidney disease |
Q51628456 | Effect of lidocaine on the hematopoietic properties of recombinant human erythropoietin in the uremic rat. |
Q33715510 | Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease |
Q46169005 | Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease |
Q92032263 | Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce |
Q53173710 | Enterococcal peritonitis in children receiving chronic peritoneal dialysis. |
Q44913988 | Epidemiology of pediatric chronic kidney disease |
Q47576199 | Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative |
Q85921357 | Erratum to: Difficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes |
Q52381514 | Estimating Time to ESRD in Children With CKD. |
Q34712999 | Estimating total body water in children on the basis of height and weight: a reevaluation of the formulas of Mellits and Cheek |
Q99212539 | Estimation of Albumin-Creatinine Ratio From Protein-Creatinine Ratio in Urine of Children and Adolescents With CKD |
Q92420182 | Ethical and Policy Considerations for Genomic Testing in Pediatric Research: The Path Toward Disclosing Individual Research Results |
Q71110619 | Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors |
Q52809168 | Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative. |
Q34751814 | Extracellular volume and glomerular filtration rate in children with chronic kidney disease |
Q46192114 | FGF23 and Left Ventricular Hypertrophy in Children with CKD. |
Q90857824 | Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States |
Q68920289 | Feeding difficulties in end-stage renal failure |
Q46004871 | Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. |
Q78352091 | Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates |
Q70545175 | Follow-up urine cultures in patients with acute pyelonephritis |
Q30703135 | Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study |
Q36866313 | Frequent hemodialysis in children |
Q53170375 | Frequent hemodialysis with NxStage system in pediatric patients receiving maintenance hemodialysis. |
Q47192914 | Fungal peritonitis in the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative |
Q34680591 | Genetic Drivers of Kidney Defects in the DiGeorge Syndrome |
Q64975564 | Genetic associations of hemoglobin in children with chronic kidney disease in the PediGFR Consortium. |
Q36790970 | Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium |
Q38872856 | Genomic Disorders and Neurocognitive Impairment in Pediatric CKD. |
Q35720119 | Genomic imbalances in pediatric patients with chronic kidney disease |
Q64073005 | Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network |
Q45071550 | Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome |
Q46737587 | Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. |
Q92612407 | Grip strength in children with chronic kidney disease |
Q37163122 | Growth in Children with Autosomal Recessive Polycystic Kidney Disease in the CKiD Cohort Study |
Q30992815 | Growth in adolescent hemodialysis patients: data from the Centers for Medicare & Medicaid Services ESRD Clinical Performance Measures Project |
Q35750743 | Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study |
Q35758263 | Growth in very young children undergoing chronic peritoneal dialysis |
Q47975779 | HLA Points Assigned in Cadaveric Kidney Allocation Should Be Revisited: An Analysis of HLA Class II Molecularly Typed Patients and Donors |
Q52287109 | HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serology. |
Q35670536 | HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort |
Q64902919 | Haemophilus influenzae type b immunization in infants on peritoneal dialysis. Pediatric Peritoneal Dialysis Study Consortium. |
Q53244678 | Health-related quality of life in pediatric patients with ESRD. |
Q36872547 | Health-related quality of life of children with mild to moderate chronic kidney disease |
Q33811638 | Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study |
Q36666815 | Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. |
Q34990962 | Hemoglobin differences by race in children with CKD. |
Q35106901 | Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort |
Q92001022 | Higher eGFR at Dialysis Initiation Is Not Associated with a Survival Benefit in Children |
Q36372581 | How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis? |
Q68694126 | Hypercalciuria in the frequency-dysuria syndrome of childhood |
Q36311232 | Hypertension in the neonatal period |
Q36315937 | Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study. |
Q73039549 | Hypogammaglobulinemia in infants and young children maintained on peritoneal dialysis. Pediatric Dialysis Study Consortium |
Q39310435 | Hypogammaglobulinemia in infants receiving chronic peritoneal dialysis |
Q43923264 | IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype |
Q72670372 | Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation |
Q36474175 | Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry |
Q46867941 | Impact of specialization of primary nephrologist on the care of pediatric hemodialysis patients |
Q40679858 | Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis |
Q36207827 | Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C |
Q50128733 | Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. |
Q90516026 | In Reply to 'The Use of Estimated GFR-Based Staging in Children With CKD: Proceed With Care' |
Q90604313 | Incidence of Initial Renal Replacement Therapy Over the Course of Kidney Disease in Children |
Q72670653 | Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient |
Q42679480 | Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? |
Q89870923 | Increased history of ischemic stroke and decreased neurocognitive performance in children with chronic kidney disease |
Q38753954 | Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription |
Q43490780 | Influence of HLA and race on long-term cadaveric renal transplantation |
Q74615986 | Influence of an historically positive crossmatch on cadaveric renal transplantation |
Q42673886 | Influence of the Rh (D) blood group system on graft survival in renal transplantation |
Q36983279 | Insights from the Chronic Kidney Disease in Children (CKiD) study |
Q89733959 | International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis |
Q70719628 | Intraperitoneal albumin infusion and pain |
Q33343594 | Invasive pneumococcal disease and hemolytic uremic syndrome |
Q47816838 | Iron therapy in the pediatric hemodialysis population |
Q47218022 | Is Blood Pressure Improving in Children With Chronic Kidney Disease? A Period Analysis |
Q43912059 | Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? |
Q30353424 | Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease |
Q38718548 | Kidney disease in children: latest advances and remaining challenges |
Q45145792 | Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. |
Q51624048 | Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection. |
Q77781397 | Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching |
Q44024976 | Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy |
Q79947887 | Long-term survival of kidneys transplanted from live A2 donors to O and B recipients |
Q44550976 | Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients |
Q78167017 | Longitudinal evaluation of transport kinetics in children receiving peritoneal dialysis |
Q37415724 | Longitudinal formulas to estimate GFR in children with CKD |
Q95935826 | Low Serum Bicarbonate and CKD Progression in Children |
Q92950735 | Maintenance Peritoneal Dialysis in Children With Autosomal Recessive Polycystic Kidney Disease: A Comparative Cohort Study of the International Pediatric Peritoneal Dialysis Network Registry |
Q36719231 | Management of anemia in children receiving chronic peritoneal dialysis |
Q38134288 | Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease |
Q33562242 | Masked hypertension associates with left ventricular hypertrophy in children with CKD |
Q50874829 | Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL). |
Q34124705 | Medication adherence and growth in children with CKD. |
Q37553087 | Medication treatment complexity and adherence in children with CKD. |
Q35983445 | Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease |
Q64244464 | Metabolomic Patterns in Adolescents With Mild to Moderate CKD |
Q91659103 | Mode of initial renal replacement therapy and transplant outcomes in the chronic kidney disease in children (CKiD) study |
Q91464918 | Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease |
Q85856514 | Mycoplasma edwardii peritonitis in a patient on maintenance peritoneal dialysis |
Q40868877 | Neonatal outcome in pregnancies associated with renal replacement therapy. |
Q48701184 | Nephrogenic fibrosing dermopathy in children. |
Q37648229 | Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease |
Q70479564 | Neuroblastoma in a renal transplanted child |
Q34207251 | Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study |
Q35165489 | Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease |
Q36633256 | Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors. |
Q36757796 | Neurocognitive, Social-Behavioral, and Adaptive Functioning in Preschool Children with Mild to Moderate Kidney Disease |
Q33797847 | Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy |
Q56969153 | Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis |
Q24642417 | New equations to estimate GFR in children with CKD |
Q37733569 | Nonlinear trajectory of GFR in children before RRT |
Q68171909 | Nutritional and behavioural aspects of nasogastric tube feeding in infants receiving chronic peritoneal dialysis |
Q38203395 | Optimal care of the infant, child, and adolescent on dialysis: 2014 update |
Q33539810 | Optimal care of the pediatric end-stage renal disease patient on dialysis |
Q98235252 | Optimizing Peritoneal Dialysis-Associated Peritonitis Prevention in the United States: From Standardized Peritoneal Dialysis-Associated Peritonitis Reporting and Beyond |
Q34190987 | Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease |
Q46148463 | Oral acetazolamide in the assessment of (urine-blood) PCO2. |
Q36774678 | Outcome of infants born to women with chronic kidney disease |
Q91120747 | Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry |
Q89819193 | Oxidant stress and renal function among children with chronic kidney disease: a repeated measures study |
Q89284311 | Parental health literacy and progression of chronic kidney disease in children |
Q87911903 | Parents Refusing Dialysis for a 3-Month-Old With Renal Failure |
Q43613353 | Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis |
Q91417327 | Pediatric intradialytic hypotension: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) Workgroup |
Q33715765 | Pediatric kidney disease: tracking onset and improving clinical outcomes. |
Q99419608 | Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry |
Q42124121 | Perceived appetite and clinical outcomes in children with chronic kidney disease. |
Q39144706 | Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and Outcomes. |
Q64084950 | Peritoneal Dialysis Vintage and Glucose Exposure but Not Peritonitis Episodes Drive Peritoneal Membrane Transformation During the First Years of PD |
Q37938688 | Peritoneal dialysis in children with end-stage renal disease |
Q37857976 | Peritoneal dialysis in infants and young children |
Q36777725 | Peritoneal dialysis in the neonatal period: outcome data. |
Q37275606 | Peritoneal dialysis prescription in children: bedside principles for optimal practice |
Q73715024 | Peritoneal dialysis workshop: pediatrics recommendations |
Q71872909 | Peritoneal membrane transport function in children receiving long-term dialysis |
Q73389804 | Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitis |
Q80507411 | Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines |
Q78516210 | Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease |
Q35952552 | Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection |
Q97547532 | Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis |
Q90802968 | Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with Chronic Kidney Disease Progression in Children |
Q92973458 | Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children |
Q69531376 | Plasma fluoride concentration in infants receiving long-term peritoneal dialysis |
Q36083206 | Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort. |
Q89733928 | Prescribing peritoneal dialysis for high-quality care in children |
Q36945418 | Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort |
Q35664594 | Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease |
Q92378749 | Prevalence and outcomes of fragility: a frailty-inflammation phenotype in children with chronic kidney disease |
Q36704667 | Prevention of peritonitis in children receiving peritoneal dialysis |
Q37311769 | Primary nocturnal enuresis: current concepts about an old problem |
Q90243084 | Prognostic Value of Ambulatory Blood Pressure Load in Pediatric CKD |
Q35278515 | Progression of pediatric CKD of nonglomerular origin in the CKiD cohort |
Q35553088 | Protein energy wasting in children with chronic kidney disease. |
Q39906591 | Psychosocial Factors That Create Barriers to Managing Serum Phosphorus Levels in Pediatric Dialysis Patients: A Retrospective Analysis |
Q99603091 | Race and ethnicity predict bone markers and fracture in pediatric patients with chronic kidney disease |
Q40508475 | Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease |
Q72541559 | Radiological cases of the month. Juvenile nephronophthisis |
Q91078408 | Recalibration of cystatin C using standardized material in Siemens nephelometers |
Q46976584 | Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type |
Q33888446 | Relapsing peritonitis in children who undergo chronic peritoneal dialysis: a prospective study of the international pediatric peritonitis registry |
Q38761109 | Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents |
Q35742679 | Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease |
Q91257992 | Renal Function and exposure to Bisphenol A and phthalates in children with Chronic Kidney Disease |
Q37416192 | Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis. |
Q79779700 | Renal graft survival is not influenced by a positive flow B-cell crossmatch |
Q47255697 | Renal replacement therapy for children throughout the world: the need for a global registry |
Q92849616 | Renal replacement therapy in the management of intoxications in children: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) workgroup |
Q73763524 | Renal structural-functional relationships in early diabetes mellitus |
Q74615189 | Renal transplantation in children with sickle cell disease: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) |
Q50619754 | Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. |
Q49287841 | Renal-pancreatic-hepatic dysplasia in siblings. |
Q39202884 | Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. |
Q93172667 | Reply to letter from A Karkar |
Q36298407 | Report of an NIH task force on research priorities in chronic kidney disease in children |
Q50621244 | Report of the American Society of Nephrology meeting. |
Q50632203 | Report of the American Society of Nephrology meetings. |
Q47353800 | Residential summer camp for children with end-stage renal disease |
Q95793045 | Response to: echocardiography assessment of the aorta in children with chronic kidney disease |
Q40638067 | Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative |
Q92998484 | Risk factors for early onset peritonitis: the SCOPE collaborative |
Q36022479 | Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. |
Q73562828 | Risk factors for mortality in infants and young children on dialysis |
Q37750540 | Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. |
Q92077870 | Safety of Laparoscopic Gastrostomy in Children Receiving Peritoneal Dialysis |
Q36990279 | Secondhand smoke exposure is associated with proteinuria in children with chronic kidney disease |
Q72007272 | Senior-Loken syndrome: revisited |
Q100537482 | Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study |
Q36006122 | Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease |
Q70255242 | Severe hypertension in an adolescent girl |
Q42643050 | Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. |
Q81140714 | Short stature and growth hormone use in pediatric hemodialysis patients |
Q90975047 | Short stature in advanced pediatric CKD is associated with faster time to reduced kidney function after transplant |
Q48564733 | Should a nonadherent adolescent receive a second kidney? |
Q73233037 | Sieving coefficient inaccuracies during hemodiafiltration in patients with hyperbilirubinemia |
Q46945369 | Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients |
Q33624282 | Sleep and fatigue symptoms in children and adolescents with CKD: a cross-sectional analysis from the chronic kidney disease in children (CKiD) study |
Q104800068 | Social Determinants of Cardiovascular Health in African American Children With CKD: An Analysis of the Chronic Kidney Disease in Children (CKiD) Study |
Q46792183 | Stratification and successful transplantation of patients awaiting ABO-incompatible (A2 into B and O) transplantation by A-isoagglutinin-titer phenogroup |
Q73490435 | Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens |
Q80250028 | Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis |
Q87238950 | Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period |
Q39487737 | Symptomatic peritoneal calcification in a child: treatment with tidal peritoneal dialysis. |
Q95842970 | Targeting optimal PD management in children: what have we learned from the IPPN registry? |
Q100407847 | Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee |
Q74150577 | Ten-year experience in transplantation of A2 kidneys into B and O recipients |
Q73876839 | Tenckhoff catheters prove superior to cook catheters in pediatric acute peritoneal dialysis |
Q89522912 | The CKiD study: overview and summary of findings related to kidney disease progression |
Q96229353 | The Improving Renal Outcomes Collaborative: Blood Pressure Measurement in Transplant Recipients |
Q34497192 | The association between abnormal birth history and growth in children with CKD. |
Q95597648 | The authors reply |
Q42920004 | The bone and mineral disorder of children undergoing chronic peritoneal dialysis |
Q44302942 | The cimetidine protocol: a convenient, accurate, and inexpensive way to measure glomerular filtration rate |
Q36719246 | The clinical impact of humoral immunity in pediatric renal transplantation. |
Q90712113 | The copy number variation landscape of congenital anomalies of the kidney and urinary tract |
Q91018669 | The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce |
Q30384469 | The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease |
Q47187170 | The effect of rhGH on height velocity and BMI in children with CKD: a report of the NAPRTCS registry |
Q36767097 | The evolving ethics of infant dialysis |
Q30411058 | The impact of short stature on health-related quality of life in children with chronic kidney disease |
Q74016820 | The impact of supplemental feeding in young children on dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study |
Q44671418 | The international pediatric peritonitis registry: a global Internet-based initiative in pediatric dialysis |
Q40784624 | The kidney in systemic disease: Part II--Autoimmune and vascular disorders |
Q71911239 | The relationship between intraperitoneal volume and solute transport in pediatric patients. Pediatric Peritoneal Dialysis Study Consortium |
Q72664901 | The renal clearance and infusion clearance of inulin are similar, but not identical |
Q38447173 | The risk for Chagas' disease in the Midwestern United States organ donor population is low. |
Q72905404 | The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients |
Q89054734 | Time-varying coefficient of determination to quantify the explanatory power of biomarkers on longitudinal GFR among children with chronic kidney disease |
Q94504138 | Timing of patient-reported renal replacement therapy planning discussions by disease severity among children and young adults with chronic kidney disease |
Q51941659 | Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. |
Q52227652 | Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. |
Q90951910 | Tunneled hemodialysis catheter care practices and blood stream infection rate in children: results from the SCOPE collaborative |
Q50027539 | Twenty-Four-Hour Ambulatory Blood Pressure versus Clinic Blood Pressure Measurements and Risk of Adverse Outcomes in Children with CKD. |
Q40976656 | Ultrasound findings in juvenile nephronophthisis |
Q35136583 | Universal GFR determination based on two time points during plasma iohexol disappearance |
Q70585444 | Unusual causes of peritonitis in three children receiving peritoneal dialysis |
Q30434562 | Urinary incontinence in the CKiD cohort and health related quality of life |
Q37032697 | Urological disorders in chronic kidney disease in children cohort: clinical characteristics and estimation of glomerular filtration rate |
Q80387828 | Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS |
Q72809668 | Use of serum creatinine concentration for estimation of glomerular filtration rate |
Q47285372 | Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease |
Q47790525 | Use of the multipurpose drainage catheter for the provision of acute peritoneal dialysis in infants and children |
Q43588171 | Validation of PD Adequest 2.0 for pediatric dialysis patients |
Q37458971 | Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children |
Q43525274 | Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis. |
Q112577233 | Variability in CKD Biomarker Studies: Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Kidney Disease Progression in the Chronic Kidney Disease in Children (CKiD) Study |
Q90210937 | Vascular Access Choice, Complications, and Outcomes in Children on Maintenance Hemodialysis: Findings From the International Pediatric Hemodialysis Network (IPHN) Registry |
Q38735500 | Vascular Stiffness in Children With Chronic Kidney Disease |
Q84966330 | Ventriculoperitoneal shunts in children on peritoneal dialysis: a survey of the International Pediatric Peritoneal Dialysis Network |
Q90215646 | Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease |
Q72695251 | Vitamin status of infants receiving long-term peritoneal dialysis |
Q45283272 | Vitamin status of pediatric patients receiving long-term peritoneal dialysis |
Q49661184 | Waist Circumference and Body Mass Index in Children with Chronic Kidney Disease and Metabolic, Cardiovascular, and Renal Outcomes. |
Q89004628 | Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease |
Q34371324 | What are the clinical correlates of adequate peritoneal dialysis? |
Q46991378 | Worldwide variation of dialysis-associated peritonitis in children |
Q71951462 | “Low-dose” growth hormone therapy during peritoneal dialysis or following renal transplantation |
Search more.